Skip to main content

Oseltamivir Phosphate

NDC 50090-6239 · A-S Medication Solutions

Generic nameOseltamivir Phosphate
Dosage formCAPSULE
RouteORAL
Active ingredient(s)OSELTAMIVIR PHOSPHATE
Strength75 mg/1
Pharmacologic classNeuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]
Marketing categoryANDA

Packages

50090-6239-0 — 10 CAPSULE in 1 BLISTER PACK (50090-6239-0)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

46708-414 — OSELTAMIVIR, 46708-415 — OSELTAMIVIR, 46708-769 — OSELTAMIVIR PHOSPHATE, 47781-384 — Oseltamivir Phosphate, 47781-468 — Oseltamivir phosphate, 47781-469 — Oseltamivir phosphate, 47781-470 — Oseltamivir phosphate, 50090-4188 — Oseltamivir Phosphate, 50090-4613 — Oseltamivir Phosphate, 50090-6099 — Oseltamivir Phosphate, 50090-7346 — oseltamivir phosphate, 50090-7347 — oseltamivir phosphate, 50090-8015 — Oseltamivir phosphate, 59651-597 — OSELTAMIVIR PHOSPHATE, 60219-1264 — Oseltamivir, 60219-1265 — Oseltamivir, 60219-1266 — Oseltamivir, 62332-413 — OSELTAMIVIR, 62332-414 — OSELTAMIVIR, 62332-415 — OSELTAMIVIR, +105 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels